Trials / Completed
CompletedNCT05842408
Clinical Trial of DA-5212 in Patients with Functional Dyspepsia
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DA-5212 in Patients with Functional Dyspepsia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 384 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate efficacy and safety of DA-5212 in patients with functional dyspepsia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-5212 | Test drug: DA-5212 |
| DRUG | DA-5212-R | Control drug: DA-5212-R |
Timeline
- Start date
- 2023-06-06
- Primary completion
- 2024-09-04
- Completion
- 2024-09-04
- First posted
- 2023-05-06
- Last updated
- 2024-12-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05842408. Inclusion in this directory is not an endorsement.